Thursday 28 May 2015, Amsterdam
The report, now available on ASDReports, “Oxidative Stress Assay Market by Product (Consumables, Instruments, Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), by Technology (ELISA, Chromatography, Flow Cytometry), by End Users - Global Forecast to 2020”, report provides a detailed overview of the major drivers, restraints, opportunities, and current market trends impacting the global oxidative stress assays market along with the estimates and forecasts of the revenue and market share analysis.
The global oxidative stress assays market is expected to reach $736.85 Million by 2020 from $452.36 Million in 2015, growing at a CAGR of 10.25%. Rapid growth in the biopharmaceutical industry, strong trend of R&D investments in biotechnology and pharmaceutical industries, technological advancements like high-content screening for drug discovery, and government funding for life science research are the primary growth drivers for this market during the forecast period (2015–2020). However, high cost of instruments, and dearth of trained professionals for new and emerging technologies may hinder the growth of this market.
The global oxidative stress assays market is segmented on the basis of products, test types, technologies, and end users. On the basis of technologies, the market is segmented into ELISA, chromatography, flow cytometry, microscopy, high-content screening, and label-free detection technology. The ELISA segment is expected to account for the largest share of the global oxidative stress assays market in 2015. However, the label-free detection technology segment is expected to grow at the highest growth rate during the forecast period.
By product, the market is divided into consumables, instruments, and services. The consumables segment is the largest segment of the market and is expected to grow at the fastest rate during the forecast period. On the basis of test types, the oxidative stress assays market is categorized into indirect assays, antioxidant capacity assays, enzyme-based assays, and reactive oxygen species (ROS)-based assays. On the basis of end users, the oxidative stress assays market is categorized into pharmaceutical and biotechnology companies, academic research institutes, clinical laboratories, and contract research organizations (CROs).
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW).
The prominent players operating in this market are Abcam plc (U.K.), AMS Biotechnology (U.K.), BioVision Incorporated (U.S.), Cell Biolabs, Inc. (U.S.), Enzo Biochem (U.S.), Merck and Co., Inc. (U.S.), Oxford Biomedical Research (U.S.), QIAGEN N.V. (Netherlands), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
ASDReports.com Media contact: S. Koopman -
Marketing and Communications
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : firstname.lastname@example.org
back to News